In Vivo Delivery of Therapeutic Molecules by Transplantation of Genome-Edited Induced Pluripotent Stem Cells

Human induced pluripotent stem cells (iPSCs) have already been used in transplantation therapies. Currently, cells from healthy people are transplanted into patients with diseases. With the rapid evolution of genome editing technology, genetic modification could be applied to enhance the therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakajima, Ittetsu, Tsukimura, Takahiro, Ono, Terumi, Shiga, Tomoko, Shitara, Hiroshi, Togawa, Tadayasu, Sakuraba, Hitoshi, Miyaoka, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186575/
https://www.ncbi.nlm.nih.gov/pubmed/37183961
http://dx.doi.org/10.1177/09636897231173734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186575/
https://www.ncbi.nlm.nih.gov/pubmed/37183961
http://dx.doi.org/10.1177/09636897231173734

Ejemplares similares